a newbie question. considering the market situation around mapmyindia listing. the gmp was 80% and listed at 50%. similarly tfor supriya lifescience, the current gmp is around 40%, do we expect 20% listing gains ? or its completely unpredictable ?
Completely unpredictable Consider the example of Medplus which was having a GMP of around 15% but listed with about 35% gains But still GMP gives a fair enough idea about negative or positive listing
Supriya Lifescience 1/2. Extremely lucky and happy as odds were 1:50. There goes my last subscribed IPO and on a good note. Time to reflect on my extremely good calendar year. Here we go -
StoveKraft 1/1 - Sold lot, 24% profit Heranba 1/1 - Sold 3/4 lot, 23% profit MTAR 1/1 - Sold half lot, 54% profit Anupam Rasayan 1/1 - Sold half lot, 6% profit Sona Comstar 2/2 - Sold 1 lot, 5% profit KIMS 1/1 - holding CarTrade 2/2 - Sold 2 lots, 34% loss Nuvoco Vistas 2/2 - sold 1 lot, 4% loss Chemplast Sanmar 1/1 - sold 3/4 lot, 22% profit Aptus Value 2/2 - sold 1 lot, 0% profit Sansera 2/2 - sold 1 lot, 6% profit ABSL AMC 1/1 - sold half lot, 9% loss PB Fintech 1/1 - holding SJS 1/1 - sold half lot, 7% loss One97 1/1 - sold lot, 22% loss Tarsons 1/2 - sold half lot, 9% profit MapmyIndia 1/2 - sold 1/2 lot, 38% profit MedPlus 1/2 - sold 1/4 lot, 40% profit
In total, made 96 applications between Jan and Dec 2021 with successful allotment of 1 in 3. Bloody good year, I would say.